Aprea Therapeutics (APRE) Q1 2025 Earnings

25MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.76
-0.67
-0.58
-0.49

Details

Expected EPS
-0.66
Actual EPS
-0.49
Surprise EPS
0.17
Surprise Percent
+25.76%

Description

Aprea Therapeutics (APRE) has reported earnings of -0.49 per share for Q1 2025.

0 Comments

Share your thoughts